Sign In

Sean Silcoff

Journalist, Author, Public Speaker, Communications Professional

Sean Silcoff is an award-winning writer known for his storytelling skills and expertise in covering various business sectors. He has a versatile writing style, ranging from news stories to in-depth analysis pieces, columns, and long-form features.

He is renowned for co-authoring 'Losing the Signal,' a critically acclaimed book that delves into the fascinating journey of BlackBerry. Sean has also offered research assistance and valuable feedback to authors working on non-fiction books.

A diligent self-starter, Sean is results-oriented and excels as a team leader and network-builder. His ability to engage with a wide range of individuals is evident in his experience interviewing Fortune 500 CEOs as well as budding student programmers.

With extensive public speaking experience, Sean has made numerous appearances on broadcast TV and radio segments, podcasts, and moderated discussions at various conferences across Canada.

Sean Silcoff's educational background includes a B.Comm in Business from Queen's University and an MJ in Journalism from Carleton University.

Sean has played key roles in various organizations throughout his career, such as his tenure as a Reporter for the Report on Business section and a Contributor for Report on Business Magazine at The Globe and Mail. He also served as the Director of Writing and Translation Services at Canada Post and worked as a Freelance Writer. Additionally, Sean has held positions including Columnist and bureau chief at National Post, Senior Writer at Canadian Business Magazine, and roles at The Globe and Mail and Cornwall Standard Freeholder.

Stay updated on Sean's insights by following him on Twitter at @SeanSilcoff or visiting muckrack.com/seansilcoff.

Highlights

Mar 2 · twitter

Xenon awaiting critical epilepsy drug study results that could lead to FDA approval for B.C. drug developer https://t.co/aqglY3gNGy https://t.co/K08PNUj709

Xenon awaiting critical epilepsy drug study results that could lead to FDA approval for B.C. drug de
Jan 19 · twitter

Dominion Dynamics, vying to become Canadian defence ‘neoprime,’ raises $21-million led by Georgian https://t.co/CxvZcti1QG https://t.co/WwWRqgrC1K

Dominion Dynamics, vying to become Canadian defence ‘neoprime,’ raises $21-million led by Georgian h
Sean Silcoff
Add to my network

Location

Greater Ottawa Metropolitan Area